TABLE 4.
Age | Number | Normal | Aneuploidy | LOH | CNV | CNV a | |||
P | LP | VOUS | LB | ||||||
35 | 299 (16.8%) | 270 (90.3%) | 6 (2.0%) | 2 (0.7%) | 21 (7.0%) | 4(1.3%) | 1 | 10 | 6 |
36 | 379 (21.2%) | 342 (90.2%) | 10 (2.6%) | 1 (0.3%) | 26 (6.9%) | 7(1.8%) | 2 | 13 | 4 |
37 | 344 (19.3%) | 303 (88.1%) | 18 (5.2%) | 2 (0.6%) | 21 (6.1%) | 5(1.5%) | 0 | 8 | 8 |
38 | 230 (12.9%) | 211 (91.7%) | 6 (2.6%) | 0 (0.0%) | 13 (5.7%) | 1(0.4%) | 2 | 6 | 4 |
39 | 170 (9.5%) | 142 (83.5%) | 11 (6.5%) | 2 (1.2%) | 15 (8.8%) | 3(1.8%) | 1 | 6 | 5 |
40 | 132 (7.4%) | 118 (89.4%) | 4 (3.0%) | 1 (0.8%) | 9 (6.8%) | 3(2.2%) | 0 | 2 | 4 |
≥41 | 230 (12.9%) | 205 (89.1%) | 19 (8.3%) | 2 (0.9%) | 4 (1.7%) | 0(0.0%) | 0 | 3 | 1 |
Total | 1784 [100] | 1591 (89.2%) | 74 (4.1%) | 10 (0.6%) | 109 (6.1%) | 23(1.3%) | 6 | 48 | 32 |
aCNVs were classified into four groups according to interpretation: P, pathogenic; LP, likely pathogenic; VOUS, variation of uncertain significance; LB, likely benign. For cases with 2 CNVs including a pathogenic CNV and a VOUS CNV were listed in the P group.